Fig. 2From: Long-term oncologic outcomes of radiotherapy combined with maximal androgen blockade for localized, high-risk prostate cancera Overall survival of cases administered MAB + EBRT and MAB + EBRT + PPB combination therapies. b PSA biochemical recurrence-free survival of cases administered MAB + EBRT and MAB + EBRT + PPB combination therapiesBack to article page